Home Cart Sign in  
Chemical Structure| 208538-73-2 Chemical Structure| 208538-73-2

Structure of Micafungin sodium
CAS No.: 208538-73-2

Chemical Structure| 208538-73-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Micafungin sodium is an echinocandin antifungal drug, Micafungin inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls.

Synonyms: FK 463 sodium; Micafungin(sodium salt); Mycamine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Micafungin sodium

CAS No. :208538-73-2
Formula : C56H70N9NaO23S
M.W : 1292.26
SMILES Code : O=S(OC1=CC([C@@H]([C@H](C2NC(C3N(C[C@@H](C3)O)C(C([C@@H](C)O)NC([C@](C[C@H]([C@H](NC(C4N(C[C@@H]([C@@H]4O)C)C(C(NC2=O)[C@@H](CC(N)=O)O)=O)=O)O)O)(NC(C5=CC=C(C=C5)C6=NOC(C7=CC=C(C=C7)OCCCCC)=C6)=O)[H])=O)=O)=O)O)O)=CC=C1O)([O-])=O.[Na+]
Synonyms :
FK 463 sodium; Micafungin(sodium salt); Mycamine
MDL No. :MFCD08067752

Safety of Micafungin sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Candida albicans SC5314 0.005 μg/ml, 0.016 μg/ml, 0.05 μg/ml 1 hour To evaluate the fungicidal effect of micafungin on Candida albicans and its impact on cellular metabolic activity. Results showed that micafungin reduced cell viability and metabolic activity in a dose-dependent manner in YPD medium, with the highest concentration (0.05 μg/ml) causing a 90% reduction in cell viability. PMC5923102
Vero cells 12.5–100 μM 2 days Micafungin significantly inhibited DENV-2 infection in a dose-dependent manner, with the most pronounced activity occurring at a concentration of 100 μM. PMC8067805
Calu-3 cells 55.3 µM (IC50) 24 hours Assessed the antiviral activity of Micafungin in human lung epithelial cells, with an IC50 of 55.3 µM PMC9958940
VeroE6/TMPRSS2 cells 26.1 µM (IC50) 24 hours Evaluated the antiviral activity of Micafungin against SARS-CoV-2, showing an IC50 of 26.1 µM PMC9958940
Candida parapsilosis ≥1 μg/ml 24 hours To evaluate the activity of Micafungin against preformed Candida parapsilosis biofilms, results showed that Micafungin at ≥1 μg/ml significantly inhibited biofilm regrowth. PMC4135876
Candida albicans ≥2 μg/ml 24 hours To evaluate the activity of Micafungin against preformed Candida albicans biofilms, results showed that Micafungin at ≥2 μg/ml significantly inhibited biofilm regrowth. PMC4135876
Candida albicans 0.002 to 1.00 mg/L 24 or 48 hours To evaluate the in vitro activity of micafungin against Candida albicans with diverse azole resistance phenotypes. Results showed that azole resistance mechanisms did not affect micafungin MIC values. PMC2532560
Vero cells 12.5–100 μM 3 days Micafungin significantly reduced viral RNA levels, with a 4.86-log reduction at 100 μM; decreased NS3 protein expression without affecting GAPDH expression; and significantly reduced viral progeny yield. PMC8067805
Candida parapsilosis (CAS-NS isolate 12) 0.25x-1xMIC (1.0–8.0 µg/mL) 3 hours To assess MICA-induced apoptosis in CAS-NS C. parapsilosis biofilms, showing 1.2–2.0-fold increase in ROS accumulation and weaker mitochondrial membrane depolarization. PMC4601157
Candida albicans (CAS-NS isolate 6) 0.25x-1xMIC (1.0–8.0 µg/mL) 3 hours To assess MICA-induced apoptosis in CAS-NS C. albicans biofilms, showing 1.2-fold increase in ROS accumulation and weaker mitochondrial membrane depolarization. PMC4601157
Candida parapsilosis (CAS-S isolate 7) 0.25x-1xMIC (1.0–8.0 µg/mL) 3 hours To assess MICA-induced apoptosis in CAS-S C. parapsilosis biofilms, showing 4.8–5.4-fold increase in ROS accumulation and significant mitochondrial membrane depolarization. PMC4601157
Candida albicans (CAS-S isolate 2) 0.25x-1xMIC (1.0–8.0 µg/mL) 3 hours To assess MICA-induced apoptosis in CAS-S C. albicans biofilms, showing 3.0–4.2-fold increase in ROS accumulation and significant mitochondrial membrane depolarization. PMC4601157
Candida parapsilosis (MICA-NS) 0.5-2 mg/L 3 hours Detected apoptosis, results showed 5-30% of cells underwent apoptosis. PMC5349207
Candida parapsilosis (MICA-S) 0.25-1 mg/L 3 hours Detected apoptosis, results showed 20-52% of cells underwent apoptosis. PMC5349207
Polymorphonuclear leukocytes (PMN) 0.05 µg/ml to 50 µg/ml 30 minutes To evaluate the effect of micafungin on PMN oxidative burst, results showed that micafungin enhanced the PMN oxidative burst dose dependently. PMC434213
Human peritoneal macrophages 0.005 μg/ml, 0.016 μg/ml, 0.05 μg/ml 4 hours To assess the immunomodulatory effect of micafungin-treated Candida albicans on human macrophages. Results demonstrated that micafungin treatment enhanced the macrophage response to C. albicans, increasing the secretion of TNF-α, IL-17A, and IL-10 cytokines. PMC5923102
Aspergillus nidulans ΔmpkA mutant 1 ng/mL 75 minutes To study the role of MpkA in the response to Micafungin-induced cell wall damage, results showed delayed and attenuated gene expression changes in the ΔmpkA mutant compared to the wild type. PMC8306900
Aspergillus nidulans wild type strain 1 ng/mL 75 minutes To study the effect of Micafungin on cell wall integrity, results showed significant gene expression changes in the wild type strain, including up-regulation of brlA. PMC8306900

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Galleria mellonella larvae Staphylococcus aureus infection model Injection 5 mg/kg Single injection, infected after 24 hours To evaluate the effect of Micafungin on larval survival, results showed Micafungin significantly extended the survival time of infected larvae. PMC4676791

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.77mL

0.15mL

0.08mL

3.87mL

0.77mL

0.39mL

7.74mL

1.55mL

0.77mL

References

 

Historical Records

Categories